Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Almodóvar González

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Reumatologia Clinica|October 30, 2012
Are spondyloarthropathies adequately referred from primary care to specialized care?Ruth López-González, Azucena Hernández-Sanz, Raquel Almodóvar-González, et al.
Reumatologia Clinica|April 13, 2016
Barriers and Facilitators for the Practice of Physical Exercise in Patients With Spondyloarthritis: Qualitative Study of Focus Groups (EJES-3D)Rafael Curbelo Rodríguez, Pedro Zarco Montejo, Raquel Almodóvar González, et al.
Reumatologia Clinica|May 10, 2022
Expert recommendations for the use of apremilast in psoriatic arthritisJuan Carlos Torre Alonso, Raquel Almodóvar González, Carlos Montilla Morales, et al.
Rheumatology International|April 11, 2020
Delphi-based recommendations for the management of cardiovascular comorbidities in patients with psoriatic arthritis and moderate-to-severe psoriasisPedro Zarco Montejo, Raquel Almodóvar González, Eva De Higes-Martínez, et al.
Reumatologia Clinica|May 22, 2013
Quality of care standards for nursing clinics in rheumatologySantiago Muñoz Fernández, Pablo Lázaro y De Mercado, Javier Alegre López, et al.
Rheumatology International|September 4, 2017
Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of SpainLaura Nuño-Nuño, Beatriz Esther Joven, Patricia E Carreira, et al.
RMD Open|October 6, 2025
Seventeen-year reassessment of diagnostic transitions, biologic therapy initiation and mortality in spondyloarthritis: results from the REGISPON-3 studyMaría Ángeles Puche-Larrubia, Lourdes Ladehesa-Pineda, María Carmen Ábalos-Aguilera, et al.
Seminars in Arthritis and Rheumatism|December 22, 2022
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patientsNuria Barroso-García, Belén Atienza-Mateo, Iván Ferraz-Amaro, et al.
Journal of Clinical Medicine|December 17, 2024
Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet's DiseaseNuria Barroso-García, José Luis Martín-Varillas, Iván Ferraz-Amaro, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2019
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 CasesBelén Atienza-Mateo, José Luis Martín-Varillas, Vanesa Calvo-Río, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Reumatologia Clinica|October 30, 2012
Are spondyloarthropathies adequately referred from primary care to specialized care?Ruth López-González, Azucena Hernández-Sanz, Raquel Almodóvar-González, et al.
Reumatologia Clinica|April 13, 2016
Barriers and Facilitators for the Practice of Physical Exercise in Patients With Spondyloarthritis: Qualitative Study of Focus Groups (EJES-3D)Rafael Curbelo Rodríguez, Pedro Zarco Montejo, Raquel Almodóvar González, et al.
Reumatologia Clinica|May 10, 2022
Expert recommendations for the use of apremilast in psoriatic arthritisJuan Carlos Torre Alonso, Raquel Almodóvar González, Carlos Montilla Morales, et al.
Rheumatology International|April 11, 2020
Delphi-based recommendations for the management of cardiovascular comorbidities in patients with psoriatic arthritis and moderate-to-severe psoriasisPedro Zarco Montejo, Raquel Almodóvar González, Eva De Higes-Martínez, et al.
Reumatologia Clinica|May 22, 2013
Quality of care standards for nursing clinics in rheumatologySantiago Muñoz Fernández, Pablo Lázaro y De Mercado, Javier Alegre López, et al.
Rheumatology International|September 4, 2017
Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of SpainLaura Nuño-Nuño, Beatriz Esther Joven, Patricia E Carreira, et al.
RMD Open|October 6, 2025
Seventeen-year reassessment of diagnostic transitions, biologic therapy initiation and mortality in spondyloarthritis: results from the REGISPON-3 studyMaría Ángeles Puche-Larrubia, Lourdes Ladehesa-Pineda, María Carmen Ábalos-Aguilera, et al.
Seminars in Arthritis and Rheumatism|December 22, 2022
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patientsNuria Barroso-García, Belén Atienza-Mateo, Iván Ferraz-Amaro, et al.
Journal of Clinical Medicine|December 17, 2024
Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet's DiseaseNuria Barroso-García, José Luis Martín-Varillas, Iván Ferraz-Amaro, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2019
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 CasesBelén Atienza-Mateo, José Luis Martín-Varillas, Vanesa Calvo-Río, et al.
Pageof 2